Conversa Health Raises $8M in Additional Series B

Conversa Health, a Portland, Ore.-based virtual care and triage platform, raised $8m in additional funding expanding its Series B financing to $20m.

With the closing of the Series B round, Conversa has raised a total of $34m. The Series B round, first announced at $12 million in June, was co-led by Builders VC and Northwell Ventures, the corporate venture arm of Northwell Health. In addition, the investor syndicate includes UH Ventures, the venture arm of University Hospitals, and venture capital firms P5 Health Ventures, Genesis Merchant Capital, J-Ventures, Epic Ventures, StartUp Health and Nassau Street Ventures.

The company intends to use the funds to continue to scale its technology platform, expand its library of automated virtual care digital pathways, and accelerate growth with new and existing customers.

Led by CEO Murray Brozinsky, Conversa provides an Automated Virtual Care and Triage platform that enables health systems to remotely monitor, analyze and communicate with patients and healthcare consumers at high frequency and scale—for chronic care, acute discharge, perioperative, oncology, OBGYN, prevention and wellness, and more. The platform automates care where possible, identifies at-risk patients, and provides digital triage to higher levels of care for those patients—e.g. phone calls, telehealth, e-visits, scheduling in-person consults—when necessary.

Conversa integrates remote patient monitoring (RPM) and other devices to incorporate vital signs and biometrics into its automated digital pathways where needed.